US20130310597A1 - Process for preparation of substituted p-aminophenol - Google Patents
Process for preparation of substituted p-aminophenol Download PDFInfo
- Publication number
- US20130310597A1 US20130310597A1 US13/948,867 US201313948867A US2013310597A1 US 20130310597 A1 US20130310597 A1 US 20130310597A1 US 201313948867 A US201313948867 A US 201313948867A US 2013310597 A1 US2013310597 A1 US 2013310597A1
- Authority
- US
- United States
- Prior art keywords
- compound
- formula
- alkyl
- reaction
- iii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 60
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical class NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 title abstract description 14
- 238000002360 preparation method Methods 0.000 title description 18
- 150000003839 salts Chemical class 0.000 claims abstract description 19
- 150000001875 compounds Chemical class 0.000 claims description 121
- 238000006243 chemical reaction Methods 0.000 claims description 55
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 54
- 239000002904 solvent Substances 0.000 claims description 45
- 239000000725 suspension Substances 0.000 claims description 36
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 26
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 25
- 238000002955 isolation Methods 0.000 claims description 24
- 239000011541 reaction mixture Substances 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 19
- 230000035484 reaction time Effects 0.000 claims description 19
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 17
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 15
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 14
- 239000012044 organic layer Substances 0.000 claims description 14
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 claims description 14
- 239000002002 slurry Substances 0.000 claims description 14
- 239000000047 product Substances 0.000 claims description 13
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 11
- 125000001072 heteroaryl group Chemical group 0.000 claims description 11
- LBKJNHPKYFYCLL-UHFFFAOYSA-N potassium;trimethyl(oxido)silane Chemical compound [K+].C[Si](C)(C)[O-] LBKJNHPKYFYCLL-UHFFFAOYSA-N 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 10
- 239000003054 catalyst Substances 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000012043 crude product Substances 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 239000010410 layer Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 125000001424 substituent group Chemical group 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims 2
- 238000007865 diluting Methods 0.000 claims 2
- 238000005406 washing Methods 0.000 claims 2
- 238000010791 quenching Methods 0.000 claims 1
- 230000000171 quenching effect Effects 0.000 claims 1
- -1 p-aminophenol compound Chemical class 0.000 abstract description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- 0 [2*]C1=C(C(C)=O)C(N)=C([4*])C([3*])=C1O Chemical compound [2*]C1=C(C(C)=O)C(N)=C([4*])C([3*])=C1O 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- 238000004128 high performance liquid chromatography Methods 0.000 description 13
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 10
- 239000000543 intermediate Substances 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 6
- 238000004949 mass spectrometry Methods 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- 235000019439 ethyl acetate Nutrition 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- SBMCKXRGHDHICL-UHFFFAOYSA-N C.CC(=O)C1=C(C)C(O)=C(C)C(C)=C1[N+](=O)[O-].CC(=O)C1=C(F)C(O)=C(CO)C=C1[N+](=O)[O-].CC(=O)C1=CC(O)=C(F)C=C1[N+](=O)[O-].CC1=C(O)C(F)=C(C(=O)O)C([N+](=O)[O-])=C1.COC1=C(C(C)=O)C([N+](=O)[O-])=C(C)C(C)=C1O.COC1=C([N+](=O)[O-])C(C(C)=O)=C(F)C(O)=C1C Chemical compound C.CC(=O)C1=C(C)C(O)=C(C)C(C)=C1[N+](=O)[O-].CC(=O)C1=C(F)C(O)=C(CO)C=C1[N+](=O)[O-].CC(=O)C1=CC(O)=C(F)C=C1[N+](=O)[O-].CC1=C(O)C(F)=C(C(=O)O)C([N+](=O)[O-])=C1.COC1=C(C(C)=O)C([N+](=O)[O-])=C(C)C(C)=C1O.COC1=C([N+](=O)[O-])C(C(C)=O)=C(F)C(O)=C1C SBMCKXRGHDHICL-UHFFFAOYSA-N 0.000 description 3
- AXAVFHFKKIFZHG-UHFFFAOYSA-N C.CC(=O)C1=C(C)C(O)=C(C)C(C)=C1[N+](=O)[O-].CC(=O)C1=C(F)C(O)=C(CO)C=C1[N+](=O)[O-].CC(=O)C1=CC(O)=C(F)C=C1[N+](=O)[O-].COC(=O)C1=C(F)C(O)=C(C)C=C1[N+](=O)[O-].COC1=C(C(C)=O)C([N+](=O)[O-])=C(C)C(C)=C1O.COC1=C([N+](=O)[O-])C(C(C)=O)=C(F)C(O)=C1C Chemical compound C.CC(=O)C1=C(C)C(O)=C(C)C(C)=C1[N+](=O)[O-].CC(=O)C1=C(F)C(O)=C(CO)C=C1[N+](=O)[O-].CC(=O)C1=CC(O)=C(F)C=C1[N+](=O)[O-].COC(=O)C1=C(F)C(O)=C(C)C=C1[N+](=O)[O-].COC1=C(C(C)=O)C([N+](=O)[O-])=C(C)C(C)=C1O.COC1=C([N+](=O)[O-])C(C(C)=O)=C(F)C(O)=C1C AXAVFHFKKIFZHG-UHFFFAOYSA-N 0.000 description 3
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 125000002619 bicyclic group Chemical group 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 238000000132 electrospray ionisation Methods 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- HBFQIOPEYZJGCO-UHFFFAOYSA-N 2,3-difluoro-4-methyl-6-nitrobenzoic acid Chemical compound CC1=CC([N+]([O-])=O)=C(C(O)=O)C(F)=C1F HBFQIOPEYZJGCO-UHFFFAOYSA-N 0.000 description 2
- WMUFBXSHPHQRCT-UHFFFAOYSA-N 2-fluoro-3-hydroxy-4-methyl-6-nitrobenzoic acid Chemical compound CC1=CC([N+]([O-])=O)=C(C(O)=O)C(F)=C1O WMUFBXSHPHQRCT-UHFFFAOYSA-N 0.000 description 2
- XEQZNNJOVGASTE-UHFFFAOYSA-N 4-fluoro-5-hydroxy-2-nitrobenzoic acid Chemical compound OC(=O)C1=CC(O)=C(F)C=C1[N+]([O-])=O XEQZNNJOVGASTE-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 2
- JXXHJWPFQHZXQJ-UHFFFAOYSA-N C.C.CC(=O)C1=C(C)C(O)=CC(C#N)=C1N.CC(=O)C1=C(F)C(O)=C(C)C=C1N.CC(=O)C1=CC(O)=C(F)C=C1N.CC(=O)C1=CC(O)=CC(C)=C1N.CC(C)OC(=O)C1=C(F)C(O)=C(CO)C=C1N.CCOC(=O)C1=C(C)C(O)=CC=C1N.COC1=C(N)C(C(C)=O)=C(C)C(O)=C1C.COC1=C(N)C(C(C)=O)=C(F)C(O)=C1C.COC1=C(N)C(C(C)=O)=C(OC)C(O)=C1C Chemical compound C.C.CC(=O)C1=C(C)C(O)=CC(C#N)=C1N.CC(=O)C1=C(F)C(O)=C(C)C=C1N.CC(=O)C1=CC(O)=C(F)C=C1N.CC(=O)C1=CC(O)=CC(C)=C1N.CC(C)OC(=O)C1=C(F)C(O)=C(CO)C=C1N.CCOC(=O)C1=C(C)C(O)=CC=C1N.COC1=C(N)C(C(C)=O)=C(C)C(O)=C1C.COC1=C(N)C(C(C)=O)=C(F)C(O)=C1C.COC1=C(N)C(C(C)=O)=C(OC)C(O)=C1C JXXHJWPFQHZXQJ-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical class [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- TXCGAZHTZHNUAI-UHFFFAOYSA-N clofibric acid Chemical compound OC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 TXCGAZHTZHNUAI-UHFFFAOYSA-N 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- IWYPVZJXNKHKRF-UHFFFAOYSA-N methyl 4-fluoro-5-hydroxy-2-nitrobenzoate Chemical compound COC(=O)C1=CC(O)=C(F)C=C1[N+]([O-])=O IWYPVZJXNKHKRF-UHFFFAOYSA-N 0.000 description 2
- ZKUUVVYMPUDTGJ-UHFFFAOYSA-N methyl 5-hydroxy-4-methoxy-2-nitrobenzoate Chemical compound COC(=O)C1=CC(O)=C(OC)C=C1[N+]([O-])=O ZKUUVVYMPUDTGJ-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- CPJSUEIXXCENMM-UHFFFAOYSA-N phenacetin Chemical compound CCOC1=CC=C(NC(C)=O)C=C1 CPJSUEIXXCENMM-UHFFFAOYSA-N 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 125000006413 ring segment Chemical group 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- HFVMEOPYDLEHBR-UHFFFAOYSA-N (2-fluorophenyl)-phenylmethanol Chemical compound C=1C=CC=C(F)C=1C(O)C1=CC=CC=C1 HFVMEOPYDLEHBR-UHFFFAOYSA-N 0.000 description 1
- 125000006652 (C3-C12) cycloalkyl group Chemical group 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- DPZHKLJPVMYFCU-UHFFFAOYSA-N 2-(5-bromopyridin-2-yl)acetonitrile Chemical compound BrC1=CC=C(CC#N)N=C1 DPZHKLJPVMYFCU-UHFFFAOYSA-N 0.000 description 1
- FYFXGOZJJNISQH-UHFFFAOYSA-N 2-amino-5-hydroxy-3-methylbenzoic acid;hydrochloride Chemical compound Cl.CC1=CC(O)=CC(C(O)=O)=C1N FYFXGOZJJNISQH-UHFFFAOYSA-N 0.000 description 1
- OZDAOHVKBFBBMZ-UHFFFAOYSA-N 2-aminopentanedioic acid;hydrate Chemical compound O.OC(=O)C(N)CCC(O)=O OZDAOHVKBFBBMZ-UHFFFAOYSA-N 0.000 description 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- HGGRAOYTQNFGGN-UHFFFAOYSA-N 4,5-difluoro-2-nitrobenzoic acid Chemical compound OC(=O)C1=CC(F)=C(F)C=C1[N+]([O-])=O HGGRAOYTQNFGGN-UHFFFAOYSA-N 0.000 description 1
- GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical compound C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 description 1
- QISOBCMNUJQOJU-UHFFFAOYSA-N 4-bromo-1h-pyrazole-5-carboxylic acid Chemical compound OC(=O)C=1NN=CC=1Br QISOBCMNUJQOJU-UHFFFAOYSA-N 0.000 description 1
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 1
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 1
- VAFJDIUJDDCMHN-UHFFFAOYSA-N 5-hydroxy-4-methoxy-2-nitrobenzoic acid Chemical compound COC1=CC([N+]([O-])=O)=C(C(O)=O)C=C1O VAFJDIUJDDCMHN-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- SSIJUKZFAVUJQU-UHFFFAOYSA-N C.COC(=O)C1=CC(O)=C(CO)C=C1[N+](=O)[O-].O=C(O)C1=CC(O)=C(CO)C=C1[N+](=O)[O-] Chemical compound C.COC(=O)C1=CC(O)=C(CO)C=C1[N+](=O)[O-].O=C(O)C1=CC(O)=C(CO)C=C1[N+](=O)[O-] SSIJUKZFAVUJQU-UHFFFAOYSA-N 0.000 description 1
- SNNMBPJANUZAAW-UHFFFAOYSA-N C.COC(=O)C1=CC(O)=C(F)C=C1[N+](=O)[O-].O=C(O)C1=CC(O)=C(F)C=C1[N+](=O)[O-] Chemical compound C.COC(=O)C1=CC(O)=C(F)C=C1[N+](=O)[O-].O=C(O)C1=CC(O)=C(F)C=C1[N+](=O)[O-] SNNMBPJANUZAAW-UHFFFAOYSA-N 0.000 description 1
- CNLYEQRLWOLCJU-UHFFFAOYSA-N C.COC(=O)C1=CC(O)=CC(C)=C1N.COC(=O)C1=CC(O)=CC(C)=C1[N+](=O)[O-].Cl Chemical compound C.COC(=O)C1=CC(O)=CC(C)=C1N.COC(=O)C1=CC(O)=CC(C)=C1[N+](=O)[O-].Cl CNLYEQRLWOLCJU-UHFFFAOYSA-N 0.000 description 1
- RUTAPKVECGKSPS-UHFFFAOYSA-N CC1=C(F)C(F)=C(C(=O)O)C([N+](=O)[O-])=C1.CC1=C(O)C(F)=C(C(=O)O)C([N+](=O)[O-])=C1.C[Si](C)(C)O[K] Chemical compound CC1=C(F)C(F)=C(C(=O)O)C([N+](=O)[O-])=C1.CC1=C(O)C(F)=C(C(=O)O)C([N+](=O)[O-])=C1.C[Si](C)(C)O[K] RUTAPKVECGKSPS-UHFFFAOYSA-N 0.000 description 1
- XMWWAZPJOSHZNG-UHFFFAOYSA-N COC(=O)C1=CC(O)=C(F)C=C1N.COC(=O)C1=CC(O)=C(F)C=C1[N+](=O)[O-] Chemical compound COC(=O)C1=CC(O)=C(F)C=C1N.COC(=O)C1=CC(O)=C(F)C=C1[N+](=O)[O-] XMWWAZPJOSHZNG-UHFFFAOYSA-N 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910017673 NH4PF6 Inorganic materials 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CXAJXXRPWCOANE-UHFFFAOYSA-M O=C(O)C1=CC(F)=C(F)C=C1[N+](=O)[O-].O=C(O)C1=CC(O)=C(F)C=C1[N+](=O)[O-].O[K] Chemical compound O=C(O)C1=CC(F)=C(F)C=C1[N+](=O)[O-].O=C(O)C1=CC(O)=C(F)C=C1[N+](=O)[O-].O[K] CXAJXXRPWCOANE-UHFFFAOYSA-M 0.000 description 1
- SJEYSFABYSGQBG-UHFFFAOYSA-M Patent blue Chemical compound [Na+].C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=CC=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1 SJEYSFABYSGQBG-UHFFFAOYSA-M 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 239000000980 acid dye Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000000987 azo dye Substances 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- YXVFYQXJAXKLAK-UHFFFAOYSA-N biphenyl-4-ol Chemical compound C1=CC(O)=CC=C1C1=CC=CC=C1 YXVFYQXJAXKLAK-UHFFFAOYSA-N 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- DEZRYPDIMOWBDS-UHFFFAOYSA-N dcm dichloromethane Chemical compound ClCCl.ClCCl DEZRYPDIMOWBDS-UHFFFAOYSA-N 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
- 239000000982 direct dye Substances 0.000 description 1
- CETRZFQIITUQQL-UHFFFAOYSA-N dmso dimethylsulfoxide Chemical compound CS(C)=O.CS(C)=O CETRZFQIITUQQL-UHFFFAOYSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- LHWWETDBWVTKJO-UHFFFAOYSA-N et3n triethylamine Chemical compound CCN(CC)CC.CCN(CC)CC LHWWETDBWVTKJO-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- OCLXJTCGWSSVOE-UHFFFAOYSA-N ethanol etoh Chemical compound CCO.CCO OCLXJTCGWSSVOE-UHFFFAOYSA-N 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- OJCSPXHYDFONPU-UHFFFAOYSA-N etoac etoac Chemical compound CCOC(C)=O.CCOC(C)=O OJCSPXHYDFONPU-UHFFFAOYSA-N 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 description 1
- 238000004896 high resolution mass spectrometry Methods 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- COTNUBDHGSIOTA-UHFFFAOYSA-N meoh methanol Chemical compound OC.OC COTNUBDHGSIOTA-UHFFFAOYSA-N 0.000 description 1
- FSUONMUAAVMIJC-UHFFFAOYSA-N methyl 2-amino-4-fluoro-5-hydroxybenzoate Chemical compound COC(=O)C1=CC(O)=C(F)C=C1N FSUONMUAAVMIJC-UHFFFAOYSA-N 0.000 description 1
- FLWFPSTYCMTANC-UHFFFAOYSA-N methyl 2-amino-5-hydroxy-3-methylbenzoate;hydrochloride Chemical compound Cl.COC(=O)C1=CC(O)=CC(C)=C1N FLWFPSTYCMTANC-UHFFFAOYSA-N 0.000 description 1
- QCBRSHAJMWLEGF-UHFFFAOYSA-N methyl 5-hydroxy-3-methyl-2-nitrobenzoate Chemical compound COC(=O)C1=CC(O)=CC(C)=C1[N+]([O-])=O QCBRSHAJMWLEGF-UHFFFAOYSA-N 0.000 description 1
- 125000006431 methyl cyclopropyl group Chemical group 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- PSACHCMMPFMFAJ-UHFFFAOYSA-N nmm n-methylmorpholine Chemical compound CN1CCOCC1.CN1CCOCC1 PSACHCMMPFMFAJ-UHFFFAOYSA-N 0.000 description 1
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229960003893 phenacetin Drugs 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000000988 sulfur dye Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/04—Formation of amino groups in compounds containing carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
Definitions
- the present invention is related to a process of preparation of a substituted p-aminophenol compound or a salt thereof.
- Substituted p-aminophenol is an organic intermediate with extensive applications. It is mainly used in pharmaceutical and dyestuff sectors. In the pharmaceutical sector it can be used in the production of p-acetaminophenol and also in the synthesis of ⁇ -p-Chlorophenoxyisobutyrate (CPIB), vitamin B1, phenacetin, composite nicotinamide and inhibitors of the hepatitis C Virus polymerase. In the dyestuff sector it is used in the production of azo dyes, direct dyes, sulfur dyes and acid dyes. Besides, p-aminophenol can also be used to synthesize many important intermediates such as p-phenylphenol. The known process of preparation of the p-aminophenol in the art, while suitable for the synthesis of small quantities, is not suitable for large scale manufacture.
- the present invention is related to a process of preparation of a compound of substituted p-aminophenol or a salt thereof.
- the present process differs from processes disclosed in the prior art, and has both technical and economical advantages over those processes, such as, for example, less expensive, commercially available starting materials; fewer synthetic steps; better yields; improved scalability; easier handling; enhanced safety; reduced contamination of the environment; and more efficient isolation and purification of the product.
- aryl refers to all-carbon monocyclic, bicyclic, or polycyclic groups of 6 to 12 carbon atoms having a completely conjugated pi-electron system, which may be optionally substituted.
- aryl include, but are not limited to: phenyl, 4-chlorophenyl, 4-fluorophenyl, 4-bromophenyl, 3-nitrophenyl, 2-methoxyphenyl, 2-methylphenyl, 3-methyphenyl, 4-methylphenyl, 4-ethylphenyl, 2-methyl-3-methoxyphenyl, 2,4-dibromophenyl, 3,5-difluorophenyl, 3,5-dimethylphenyl, 2,4,6-trichlorophenyl, 4-methoxyphenyl, naphthyl, 2-chloronaphthyl, 2,4-dimethoxyphenyl, 4-(trifluoromethyl)phenyl, and 2-iodo-4-methyl
- heteroaryl refer to a substituted or unsubstituted monocyclic, bicyclic, or polycyclic group of 5 to 12 ring atoms containing one or more ring heteroatoms selected from N, O, and S, the remaining ring atoms being C, and, in addition, having a completely conjugated pi-electron system.
- heteroaryl rings examples include, but are not limited to, furyl, thienyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, tetrazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, and triazinyl.
- heteroaryl also include heteroaryl rings with fused carbocyclic ring systems that are partially or fully unsaturated, such as a benzene ring, to form a benzofused heteroaryl.
- heteroaryl include fused 5-6, 5-5, 6-6 ring systems, optionally possessing one nitrogen atom at a ring junction.
- examples of such hetaryl rings include, but are not limited to, pyrrolopyrimidinyl, imidazo[1,2-a]pyridinyl, imidazo[2,1-b]thiazolyl, imidazo[4,5-b]pyridine, pyrrolo[2,1-f][1,2,4]triazinyl, and the like.
- Heteroaryl groups may be attached to other groups through their carbon atoms or the heteroatom(s), if applicable. For example, pyrrole may be connected at the nitrogen atom or at any of the carbon atoms.
- (C 1 -C 6 )alkyl includes both branched and straight chain alkyl groups.
- Typical alkyl groups contemplated by the present invention include methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, n-hexyl, and the like.
- (C 3 -C 12 )cycloalkyl refers to a 3-12 carbon mono-cyclic, bicyclic, or polycyclic aliphatic ring structure, optionally substituted with for example, alkyl, hydroxy, oxo, and halo, such as cyclopropyl, methylcyclopropyl, cyclobutyl, cyclopentyl, 2-hydroxycyclopentyl, cyclohexyl, 4-chlorocyclohexyl, cycloheptyl, cyclooctyl, and the like.
- halo refers to fluoro, chloro, bromo, or iodo.
- salt refers to salts prepared from chemically or pharmaceutical acceptable non-toxic acids.
- a compound of the present invention is basic, its corresponding salt can be conveniently prepared from chemically or pharmaceutically acceptable non-toxic acids, including inorganic and organic acids.
- Such acids include, for example, acetic, benzenesulfonic, benzoic, camphorsulfonic, citric, ethanesulfonic, fumaric, gluconic, glutamic, hydrobromic, hydrochloric, isethionic, lactic, maleic, malic, mandelic, methanesulfonic, mucic, nitric, pamoic, pantothenic, phosphoric, succinic, sulfuric, tartaric, p-toluenesulfonic acid and the like.
- Particularly preferred are citric, hydrobromic, hydrochloric, maleic, phosphoric, sulfuric and tartaric acids.
- purification in the context of purification of product from reaction mixture refers to chromatograph and/or recrystallization.
- One embodiment of the present invention is related to a process of preparing a compound of formula (I) or a salt thereof,
- R 1 is (C 1-6 )alkyl, or (C 3-12 )cycloalkyl
- R 2 , R 3 , and R 4 are each independently selected from H, F, Cl, CF 3 , CN, —OH, —NH 2 , (C 1-6 )alkyl, (C 3-12 )cycloalkyl, —O—(C 1-6 )alkyl, —NH(C 1-6 )alkyl, —NH(C 3-12 )cycloalkyl, —N((C 1-6 )alkyl(C 3-12 )cycloalkyl) and —N((C 1-6 )alkyl) 2 ; wherein each of R 1 to R 4 is optionally substituted by one or more substituents selected from H, F, Cl, CF 3 , OXO, CF 3 , CN, (C 1-6 )alkyl, (C 3-12 )cycloalkyl, —OH, —SH, —O(C 1-6 )alkyl, —S(C 1-6 )alkyl, —NH 2
- Step A converting a compound of formula (II) to a compound of formula (III) according to reaction scheme 1:
- Step B converting the compound of formula (III) to a compound of formula (IV) according to reaction scheme 2:
- Step C converting the compound for formula (IV) to a compound of formula (I) according to reaction scheme 3:
- the compound of Formula (II) is reacted with a suitable amount of potassium trimethylsilanolate (TMSOK) in the presence of a suitable solvent at a suitable reaction temperature for a suitable reaction time to provide the compound of formula (III), wherein said compound of formula (III) is obtained via a suitable isolation procedure.
- Said suitable solvent includes, but is not limited to, dimethylformamide (DMF), dimethylacetamide (DMAc), diethyleneglycol dimethylether (Diglyme), 2-methyltetrahydrofuran (MeTHF), acetonitrile, tetrahydrofuran or mixture of two or more of the solvents.
- the solvent is 2-methyltetrahydrofuran (MeTHF).
- Said reaction temperature is from 50° C. to 80° C., and preferably from 65° C. to 70° C.
- Said reaction time is from 2 to 3 hours after addition of the compound of formula (II) into the reaction is complete.
- Said suitable amount of potassium trimethylsilanolate (TMSOK) is from 3 to 3.5 equivalents compared to the amount of the compound of formula (II).
- the reaction mixture is cooled to room temperature, then quenches the reaction by adding water, adjusts the pH of the reaction mixture to be acidic, separates the organic layer from the aqueous layer of the reaction mixture, washes the organic layer with water, reduces the volume of organic layer to form a residue of the crude product, stirs the residue of the crude product in a solvent to form a slurry suspension
- said solvent includes, but is not limited to, Methyl tert-butyl ether (MTBE), hexane, ether, petroleum ether, methanol, benzene, water, ethanol, acetonitrile, tetrahydrofuran, toluene, methylcyclohexane or mixture of two or more of the solvents, preferably a mixture of toluene and methylcyclohexane wherein the volume ratio of toluene and methylcyclohexane is
- the yield of the compound of formula (III) is at least about 90%, and the compound of formula (III) is obtained on a scale of at least 30 grams without purification.
- the above-described reaction is preferably carried out at about atmospheric pressure although higher or lower pressures are used if desired.
- Another embodiment of the invention relates to a process for Step A wherein the compound of Formula II is reacted with a suitable amount of KOH, or NaOH to provide a compound of Formula III wherein said compound III is obtained via a suitable isolation procedure.
- a preferred list of compounds of Formula (III) synthesized according to scheme 1 is selected from the group consisting of:
- the compound of formula (III) is reacted with a suitable amount of oxalyl chloride in the presence of a suitable solvent and at a suitable reaction temperature for a suitable reaction time to form an acid chloride intermediate; and then said acid chloride intermediate is reacted with a suitable amount of alcohol at a suitable reaction temperature for a suitable reaction time to provide the compound of formula (IV), wherein said compound of formula (IV) is obtained via a suitable isolation procedure.
- Said suitable solvent includes, but is not limited to, 2-methyltetrahydrofuran (MeTHF), acetonitrile, tetrahydrofuran, toluene or mixture of two or more of the solvents.
- the solvent is 2-methyltetrahydrofuran (MeTHF).
- Said suitable reaction temperature to form the acid chloride intermediate is from 10° C. to 30° C., preferably 20° C.
- Said reaction time to form the acid chloride intermediate is from 1 to 2 hours after addition of oxalyl chloride into the reaction is complete.
- Said suitable amount of oxalyl chloride is from 1 to 1.5 equivalents compared to the amount of the compound of formula (III), preferably 1.25 equivalents compared to the amount of the compound of formula (III).
- Said alcohol includes, but is not limited to, methanol, ethanol, propanol, butanol, isopropanol, or t-butanol.
- the alcohol is anhydrous methanol.
- Said suitable amount of alcohol is from 5 to 15 equivalents compared to the amount of the compound of formula (III), preferably 10 equivalents compared to the amount of the compound of formula (III).
- Said suitable reaction temperature to convert the acid chloride intermediate to the compound of formula (IV) is from 10° C. to 30° C., and preferably 20° C.
- Said reaction time to convert the acid chloride intermediate to the compound of formula (IV) is from 2 to 4 hours after addition of the alcohol into the reaction is complete.
- the pH of the reaction mixture is adjusted to be neutral by adding basic reagents into the reaction mixture, then separates the organic layer from the aqueous layer of the reaction mixture, reduces the volume of organic layer to form a residue of the crude product, stirs the residue of the crude product in a solvent to form a slurry suspension
- said solvent includes, but is not limited to, Methyl tert-butyl ether (MTBE), hexane, ether, petroleum ether, methanol, benzene, water, ethanol, acetonitrile, tetrahydrofuran, toluene, methylcyclohexane or mixture of two or more of the solvents, preferably a mixture of toluene and hexane wherein the volume ratio of toluene and hexane is 2:1, filtering the slurry suspension, and drying the solid to provide the compound of formula (IV
- the yield of the compound of formula (IV) is at least about 92%, and the compound of formula (IV) is obtained on a scale of at least 30 grams without purification.
- the above-described reaction is preferably carried out at about atmospheric pressure although higher or lower pressures are used if desired.
- Another embodiment of the invention relates to a process for Step B wherein a compound of formula III is reacted with a suitable amount of sulfuric acid, MeOH to provide a compound of formula IV wherein said compound of formula IV is obtained via a suitable isolation procedure.
- a preferred list of compounds of Formula (IV) synthesized according to scheme 2 is selected from the group consisting of:
- the compound of formula (IV) is hydrogenated in the presence of a suitable amount of a suitable catalyst, a suitable solvent and at a suitable reaction temperature to provide a compound of formula (I), wherein said compound of formula (I) is obtained via a suitable isolation procedure.
- a suitable solvent includes, but is not limited to, methanol, ethanol, water, acetic acid or mixture of two or more of the solvents, preferably methanol.
- Said catalyst includes, but is not limited to, palladium on carbon. The preferable catalyst is 5% palladium on carbon.
- Said suitable amount of the catalyst is from 0.001 to 0.05 equivalent compared to the amount of the compound of formula (IV), preferably 0.005 equivalent compared to the amount of the compound of formula (IV).
- Said reaction temperature is from 20° C. to 70° C., and preferably is from 20° C. to 25° C.
- the yield is at least 99.5% as analyzed by HPLC
- the reaction mixture is diluted with tetrahydrofuran (THF), then filters the resulting mixture through a Celite pad, concentrates the filtrate and dries the filtrate to provide the compound of formula (I).
- the yield of the compound of formula (I) is at least about 90%, and the compound of formula (I) is obtained on a scale of at least 20 grams without purification.
- Another embodiment of the invention relates to a process wherein a compound of formula IV is hydrogenated with palladium on carbon apparatus and then isolated using a suitable isolation procedure.
- Another embodiment of the present invention is related to a process of preparation of a salt of the compound of formula (I).
- a solvent is added into the compound of formula (I) obtained from Step C as described above to form a suspension, then a suitable acid is added into the suspension at a rate where the temperature of the suspension is maintained below a suitable temperature, and the suspension is stirred at a suitable temperature for a suitable reaction time to provide the salt of the compound of formula (I), wherein said salt of the compound of formula (I) is obtained via a suitable isolation procedure.
- Said solvent includes, but is not limited to, acetone, acetonitrile, tetrahydrofuran, ethyl acetate or mixture of two or more of the solvents.
- the solvent is ethyl acetate.
- Said acid comprises acetic, benzenesulfonic, benzoic, camphorsulfonic, citric, ethanesulfonic, fumaric, gluconic, glutamic, hydrobromic, hydrochloric, isethionic, lactic, maleic, malic, mandelic, methanesulfonic, mucic, nitric, pamoic, pantothenic, phosphoric, succinic, sulfuric, tartaric, or p-toluenesulfonic acid.
- the acid is hydrochloric acid.
- the temperature of the suspension is maintained below 30° C. during the period of addition of the acid into the suspension.
- the suitable temperature of stirring the suspension after the completion of the addition of acid is from 20° C. to 50° C., preferably 20° C.
- Said suitable reaction time is from 1 to 4 hours after addition of the acid into the suspension is complete, preferably 2 hours after addition of the acid into the suspension is complete.
- the suspension is filtered, and the solid is dried to provide the salt of the compound of formula (I).
- the yield of the salt of the compound of formula (I) is at least about 90%, and the salt of the compound of formula (I) is obtained on a scale of at least 22 grams without purification.
- any of the above and/or following synthetic sequences it may be necessary and/or desirable to protect sensitive or reactive groups on any of the molecules concerned. This can be achieved by means of conventional protecting groups, such as those described in T. W. Greene, Protective Groups in Organic Chemistry, John Wiley & Sons, 1981; T. W. Greene and P. G. M. Wuts, Protective Groups in Organic Chemistry, John Wiley & Sons, 1991, and T. W. Greene and P. G. M. Wuts, Protective Groups in Organic Chemistry, John Wiley & Sons, 1999, which are hereby incorporated by reference.
- conventional protecting groups such as those described in T. W. Greene, Protective Groups in Organic Chemistry, John Wiley & Sons, 1981; T. W. Greene and P. G. M. Wuts, Protective Groups in Organic Chemistry, John Wiley & Sons, 1991, and T. W. Greene and P. G. M. Wuts, Protective Groups in Organic Chemistry, John Wiley &
- TLC thin layer chromatography
- HPLC HPLC
- AgilentTM Plus C18 4.6 ⁇ 150 mm, Part Number: 959994-902, 1.8 ⁇ M
- the flow rate and run time are adjusted to the samples being analyzed.
- UV detection is at 224 and/or 254 nm.
- 1 HNMR (400 MHz or 300 MHz) and 13 C NMR (100.6 MHz) spectra were recorded on Bruker or Varian instruments at ambient temperature with TMS or the residual solvent peak as the internal standard.
- the line positions or multiples are given in ppm ( ⁇ ) and the coupling constants (J) are given as absolute values in Hertz (Hz).
- the multiplicities in 1 H NMR spectra are abbreviated as follows: s (singlet), d (doublet), t (triplet), q (quartet), quint (quintet), m (multiplet), m c (centered multiplet), br or broad (broadened), AA′BB′.
- the signal multiplicities in 13 C NMR spectra were determined using the DEPT135 pulse sequence and are abbreviated as follows: +(CH or CH 3 ), —(CH 2 ), C quart (C).
- TMSOK potassium trimethylsilanolate
- 2-methyl tetrahydrofuran 240 mL
- 2-MeTHF 2-MeTHF
- the addition is exothermic and the temperature of the reaction mixture rises to 40-50° C. during addition.
- the jacket temperature is set at 65-70° C.
- the suspension is stirred for 2-3 hour, until HPLC sample shows complete conversion.
- the mixture is cooled down to room temp.
- the reaction is quenched with water (100 mL), and acidified to pH 1 with HCl aqueous solution (6M, 90 mL).
- the layers are separated.
- the upper organic layer is washed with water (150 mL), and distilled under vacuum to minimum volume.
- the dark brown residue is stirred in 200 mL of mixed solvent of toluene/methylcyclohexane (v/v, 2:1) to give a suspension.
- the slurry is filtered.
- the solid is dried under vacuum to provide the desired product, 2-fluoro-3-hydroxy-4-methyl-6-nitrobenzoic acid (29 g, 90% yield).
- the mixture was cooled down to room temperature, acidified to pH 1 with concentrated HCl solution (105 ml, 1.26 mol, 3.2 eq), and extracted with 2-methyltetrahydrofuran (630 mL). The layers were separated. The upper organic layer was washed with water (150 mL), and distilled under vacuum to minimum volume.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
- Priority is hereby claimed to U.S. Provisional Application No. 61/248,717 filed on Oct. 5, 2010.
- The present invention is related to a process of preparation of a substituted p-aminophenol compound or a salt thereof.
- Substituted p-aminophenol is an organic intermediate with extensive applications. It is mainly used in pharmaceutical and dyestuff sectors. In the pharmaceutical sector it can be used in the production of p-acetaminophenol and also in the synthesis of α-p-Chlorophenoxyisobutyrate (CPIB), vitamin B1, phenacetin, composite nicotinamide and inhibitors of the hepatitis C Virus polymerase. In the dyestuff sector it is used in the production of azo dyes, direct dyes, sulfur dyes and acid dyes. Besides, p-aminophenol can also be used to synthesize many important intermediates such as p-phenylphenol. The known process of preparation of the p-aminophenol in the art, while suitable for the synthesis of small quantities, is not suitable for large scale manufacture.
- There is a continuing need to develop alternative processes of preparation of substituted p-aminophenol with fewer synthetic steps, improved scalability, more efficient isolation and purification of the product, easier handling, better yields, less reaction time, less consumption of starting materials, enhanced safety, reduced contamination to the environment, and reduced costs associated with the process.
- The present invention is related to a process of preparation of a compound of substituted p-aminophenol or a salt thereof. The present process differs from processes disclosed in the prior art, and has both technical and economical advantages over those processes, such as, for example, less expensive, commercially available starting materials; fewer synthetic steps; better yields; improved scalability; easier handling; enhanced safety; reduced contamination of the environment; and more efficient isolation and purification of the product.
- As used herein, the term “aryl” refers to all-carbon monocyclic, bicyclic, or polycyclic groups of 6 to 12 carbon atoms having a completely conjugated pi-electron system, which may be optionally substituted. Examples of aryl include, but are not limited to: phenyl, 4-chlorophenyl, 4-fluorophenyl, 4-bromophenyl, 3-nitrophenyl, 2-methoxyphenyl, 2-methylphenyl, 3-methyphenyl, 4-methylphenyl, 4-ethylphenyl, 2-methyl-3-methoxyphenyl, 2,4-dibromophenyl, 3,5-difluorophenyl, 3,5-dimethylphenyl, 2,4,6-trichlorophenyl, 4-methoxyphenyl, naphthyl, 2-chloronaphthyl, 2,4-dimethoxyphenyl, 4-(trifluoromethyl)phenyl, and 2-iodo-4-methylphenyl.
- The terms “heteroaryl” refer to a substituted or unsubstituted monocyclic, bicyclic, or polycyclic group of 5 to 12 ring atoms containing one or more ring heteroatoms selected from N, O, and S, the remaining ring atoms being C, and, in addition, having a completely conjugated pi-electron system. Examples of such heteroaryl rings include, but are not limited to, furyl, thienyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, tetrazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, and triazinyl. The terms “heteroaryl” also include heteroaryl rings with fused carbocyclic ring systems that are partially or fully unsaturated, such as a benzene ring, to form a benzofused heteroaryl. For example, benzimidazole, benzoxazole, benzothiazole, benzofuran, quinoline, isoquinoline, quinoxaline, indole, and the like. Furthermore, the terms “heteroaryl” include fused 5-6, 5-5, 6-6 ring systems, optionally possessing one nitrogen atom at a ring junction. Examples of such hetaryl rings include, but are not limited to, pyrrolopyrimidinyl, imidazo[1,2-a]pyridinyl, imidazo[2,1-b]thiazolyl, imidazo[4,5-b]pyridine, pyrrolo[2,1-f][1,2,4]triazinyl, and the like. Heteroaryl groups may be attached to other groups through their carbon atoms or the heteroatom(s), if applicable. For example, pyrrole may be connected at the nitrogen atom or at any of the carbon atoms.
- The term “(C1-C6)alkyl” includes both branched and straight chain alkyl groups. Typical alkyl groups contemplated by the present invention include methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, n-hexyl, and the like.
- Unless otherwise specified, the term “(C3-C12)cycloalkyl” refers to a 3-12 carbon mono-cyclic, bicyclic, or polycyclic aliphatic ring structure, optionally substituted with for example, alkyl, hydroxy, oxo, and halo, such as cyclopropyl, methylcyclopropyl, cyclobutyl, cyclopentyl, 2-hydroxycyclopentyl, cyclohexyl, 4-chlorocyclohexyl, cycloheptyl, cyclooctyl, and the like.
- The term “halo” refers to fluoro, chloro, bromo, or iodo.
- The term “salt” refers to salts prepared from chemically or pharmaceutical acceptable non-toxic acids. When a compound of the present invention is basic, its corresponding salt can be conveniently prepared from chemically or pharmaceutically acceptable non-toxic acids, including inorganic and organic acids. Such acids include, for example, acetic, benzenesulfonic, benzoic, camphorsulfonic, citric, ethanesulfonic, fumaric, gluconic, glutamic, hydrobromic, hydrochloric, isethionic, lactic, maleic, malic, mandelic, methanesulfonic, mucic, nitric, pamoic, pantothenic, phosphoric, succinic, sulfuric, tartaric, p-toluenesulfonic acid and the like. Particularly preferred are citric, hydrobromic, hydrochloric, maleic, phosphoric, sulfuric and tartaric acids.
- The term “purification” in the context of purification of product from reaction mixture refers to chromatograph and/or recrystallization.
-
TABLE 1 Abbreviations Bn Benzyl group Boc tert-butoxycarbonyl br Broad CD3OD Deuterated methanol CDCl3 Deuterated chloroform d Doublet DCM dichloromethane dd Doublet of doublets DIEA diisopropylethylamine DMF N,N-dimethylformamide DMSO dimethyl sulphoxide ESI Electrospray Ionization for mass spectrometry Et3N triethylamine EtOAc ethyl acetate EtOH ethanol HCl Hydrochloric acid HRMS High Resolution Mass Spectroscopy (electrospray ionization positive scan) LCMS Liquid Chromatography - Mass Spectroscopy LRMS Low Resolution Mass Spectroscopy (electrospray or thermospray ionization positive scan) LRMS (ES−) Low Resolution Mass Spectroscopy (electrospray ionization negative scan) m Multiplet m/z Mass spectrum peak MeOH methanol MHz Megahertz MS Mass spectroscopy NaH Sodium hydride NMM N-methylmorpholine NMP 1-methyl-2-pyrrolidinone NMR Nuclear Magnetic Resonance Pg. Page q Quartet Rpm Revolutions per minute s Singlet t Triplet TFA trifluoroacetic acid THF Tetrahydrofuran TLC Thin layer chromatography Vol. Volume δ Chemical shift - One embodiment of the present invention is related to a process of preparing a compound of formula (I) or a salt thereof,
- wherein
- R1 is (C1-6)alkyl, or (C3-12)cycloalkyl;
- R2, R3, and R4 are each independently selected from H, F, Cl, CF3, CN, —OH, —NH2, (C1-6)alkyl, (C3-12)cycloalkyl, —O—(C1-6)alkyl, —NH(C1-6)alkyl, —NH(C3-12)cycloalkyl, —N((C1-6)alkyl(C3-12)cycloalkyl) and —N((C1-6)alkyl)2; wherein each of R1 to R4 is optionally substituted by one or more substituents selected from H, F, Cl, CF3, OXO, CF3, CN, (C1-6)alkyl, (C3-12)cycloalkyl, —OH, —SH, —O(C1-6)alkyl, —S(C1-6)alkyl, —NH2, —NH(C1-6)alkyl, aryl and heteroaryl; comprising:
- Step A: converting a compound of formula (II) to a compound of formula (III) according to reaction scheme 1:
- wherein the compound of Formula (I) is reacted with a suitable amount of potassium trimethylsilanolate (TMSOK) in the presence of a suitable solvent at a suitable reaction temperature for a suitable reaction time to provide the compound of formula (III), wherein said compound of formula (III) is obtained via a suitable isolation procedure;
- Step B: converting the compound of formula (III) to a compound of formula (IV) according to reaction scheme 2:
- wherein the compound of formula (III) is reacted with a suitable amount of oxalyl chloride in the presence of a suitable solvent and at a suitable reaction temperature for a suitable reaction time to form an acid chloride intermediate; and then said acid chloride intermediate is reacted with a suitable amount of alcohol at a suitable reaction temperature for a suitable reaction time to provide the compound of formula (IV), wherein said compound of formula (IV) is obtained via a suitable isolation procedure; and
- Step C: converting the compound for formula (IV) to a compound of formula (I) according to reaction scheme 3:
- wherein the compound of formula (IV) is hydrogenated in the presence of a suitable amount of a suitable catalyst, a suitable solvent and at a suitable reaction temperature to provide a compound of formula (I), wherein said compound of formula (I) is obtained via a suitable isolation procedure.
- In a typical preparation of the compound of formula (III) as described in scheme 1, the compound of Formula (II) is reacted with a suitable amount of potassium trimethylsilanolate (TMSOK) in the presence of a suitable solvent at a suitable reaction temperature for a suitable reaction time to provide the compound of formula (III), wherein said compound of formula (III) is obtained via a suitable isolation procedure. Said suitable solvent includes, but is not limited to, dimethylformamide (DMF), dimethylacetamide (DMAc), diethyleneglycol dimethylether (Diglyme), 2-methyltetrahydrofuran (MeTHF), acetonitrile, tetrahydrofuran or mixture of two or more of the solvents. Preferably, the solvent is 2-methyltetrahydrofuran (MeTHF). Said reaction temperature is from 50° C. to 80° C., and preferably from 65° C. to 70° C. Said reaction time is from 2 to 3 hours after addition of the compound of formula (II) into the reaction is complete. Said suitable amount of potassium trimethylsilanolate (TMSOK) is from 3 to 3.5 equivalents compared to the amount of the compound of formula (II). Upon the conversion, the product yield is at least 99.5% as analyzed by HPLC, the reaction mixture is cooled to room temperature, then quenches the reaction by adding water, adjusts the pH of the reaction mixture to be acidic, separates the organic layer from the aqueous layer of the reaction mixture, washes the organic layer with water, reduces the volume of organic layer to form a residue of the crude product, stirs the residue of the crude product in a solvent to form a slurry suspension wherein said solvent includes, but is not limited to, Methyl tert-butyl ether (MTBE), hexane, ether, petroleum ether, methanol, benzene, water, ethanol, acetonitrile, tetrahydrofuran, toluene, methylcyclohexane or mixture of two or more of the solvents, preferably a mixture of toluene and methylcyclohexane wherein the volume ratio of toluene and methylcyclohexane is 2:1, filters the slurry suspension, and dries the solid to provide the compound of formula (III). The yield of the compound of formula (III) is at least about 90%, and the compound of formula (III) is obtained on a scale of at least 30 grams without purification. The above-described reaction is preferably carried out at about atmospheric pressure although higher or lower pressures are used if desired.
- Another embodiment of the invention relates to a process for Step A wherein the compound of Formula II is reacted with a suitable amount of KOH, or NaOH to provide a compound of Formula III wherein said compound III is obtained via a suitable isolation procedure.
- A preferred list of compounds of Formula (III) synthesized according to scheme 1 is selected from the group consisting of:
- In a typical preparation of the compound of formula (IV) as described in scheme 2, the compound of formula (III) is reacted with a suitable amount of oxalyl chloride in the presence of a suitable solvent and at a suitable reaction temperature for a suitable reaction time to form an acid chloride intermediate; and then said acid chloride intermediate is reacted with a suitable amount of alcohol at a suitable reaction temperature for a suitable reaction time to provide the compound of formula (IV), wherein said compound of formula (IV) is obtained via a suitable isolation procedure. Said suitable solvent includes, but is not limited to, 2-methyltetrahydrofuran (MeTHF), acetonitrile, tetrahydrofuran, toluene or mixture of two or more of the solvents. Preferably, the solvent is 2-methyltetrahydrofuran (MeTHF). Said suitable reaction temperature to form the acid chloride intermediate is from 10° C. to 30° C., preferably 20° C. Said reaction time to form the acid chloride intermediate is from 1 to 2 hours after addition of oxalyl chloride into the reaction is complete. Said suitable amount of oxalyl chloride is from 1 to 1.5 equivalents compared to the amount of the compound of formula (III), preferably 1.25 equivalents compared to the amount of the compound of formula (III). Said alcohol includes, but is not limited to, methanol, ethanol, propanol, butanol, isopropanol, or t-butanol. Preferably the alcohol is anhydrous methanol. Said suitable amount of alcohol is from 5 to 15 equivalents compared to the amount of the compound of formula (III), preferably 10 equivalents compared to the amount of the compound of formula (III). Said suitable reaction temperature to convert the acid chloride intermediate to the compound of formula (IV) is from 10° C. to 30° C., and preferably 20° C. Said reaction time to convert the acid chloride intermediate to the compound of formula (IV) is from 2 to 4 hours after addition of the alcohol into the reaction is complete. Upon the conversion the yield of the product is at least 99.5% pure as analyzed by HPLC, the pH of the reaction mixture is adjusted to be neutral by adding basic reagents into the reaction mixture, then separates the organic layer from the aqueous layer of the reaction mixture, reduces the volume of organic layer to form a residue of the crude product, stirs the residue of the crude product in a solvent to form a slurry suspension wherein said solvent includes, but is not limited to, Methyl tert-butyl ether (MTBE), hexane, ether, petroleum ether, methanol, benzene, water, ethanol, acetonitrile, tetrahydrofuran, toluene, methylcyclohexane or mixture of two or more of the solvents, preferably a mixture of toluene and hexane wherein the volume ratio of toluene and hexane is 2:1, filtering the slurry suspension, and drying the solid to provide the compound of formula (IV). The yield of the compound of formula (IV) is at least about 92%, and the compound of formula (IV) is obtained on a scale of at least 30 grams without purification. The above-described reaction is preferably carried out at about atmospheric pressure although higher or lower pressures are used if desired.
- Another embodiment of the invention relates to a process for Step B wherein a compound of formula III is reacted with a suitable amount of sulfuric acid, MeOH to provide a compound of formula IV wherein said compound of formula IV is obtained via a suitable isolation procedure.
- A preferred list of compounds of Formula (IV) synthesized according to scheme 2 is selected from the group consisting of:
- In a typical preparation of the compound of formula (I) as described in scheme 3, the compound of formula (IV) is hydrogenated in the presence of a suitable amount of a suitable catalyst, a suitable solvent and at a suitable reaction temperature to provide a compound of formula (I), wherein said compound of formula (I) is obtained via a suitable isolation procedure. Said suitable solvent includes, but is not limited to, methanol, ethanol, water, acetic acid or mixture of two or more of the solvents, preferably methanol. Said catalyst includes, but is not limited to, palladium on carbon. The preferable catalyst is 5% palladium on carbon. Said suitable amount of the catalyst is from 0.001 to 0.05 equivalent compared to the amount of the compound of formula (IV), preferably 0.005 equivalent compared to the amount of the compound of formula (IV). Said reaction temperature is from 20° C. to 70° C., and preferably is from 20° C. to 25° C. Upon the conversion of the product, the yield is at least 99.5% as analyzed by HPLC, the reaction mixture is diluted with tetrahydrofuran (THF), then filters the resulting mixture through a Celite pad, concentrates the filtrate and dries the filtrate to provide the compound of formula (I). The yield of the compound of formula (I) is at least about 90%, and the compound of formula (I) is obtained on a scale of at least 20 grams without purification.
- Another embodiment of the invention relates to a process wherein a compound of formula IV is hydrogenated with palladium on carbon apparatus and then isolated using a suitable isolation procedure.
- Another embodiment of the present invention is related to a process of preparation of a salt of the compound of formula (I). In a typical preparation of the salt of the compound of formula (I), a solvent is added into the compound of formula (I) obtained from Step C as described above to form a suspension, then a suitable acid is added into the suspension at a rate where the temperature of the suspension is maintained below a suitable temperature, and the suspension is stirred at a suitable temperature for a suitable reaction time to provide the salt of the compound of formula (I), wherein said salt of the compound of formula (I) is obtained via a suitable isolation procedure. Said solvent includes, but is not limited to, acetone, acetonitrile, tetrahydrofuran, ethyl acetate or mixture of two or more of the solvents. Preferably, the solvent is ethyl acetate. Said acid comprises acetic, benzenesulfonic, benzoic, camphorsulfonic, citric, ethanesulfonic, fumaric, gluconic, glutamic, hydrobromic, hydrochloric, isethionic, lactic, maleic, malic, mandelic, methanesulfonic, mucic, nitric, pamoic, pantothenic, phosphoric, succinic, sulfuric, tartaric, or p-toluenesulfonic acid. Preferably, the acid is hydrochloric acid. The temperature of the suspension is maintained below 30° C. during the period of addition of the acid into the suspension. The suitable temperature of stirring the suspension after the completion of the addition of acid is from 20° C. to 50° C., preferably 20° C. Said suitable reaction time is from 1 to 4 hours after addition of the acid into the suspension is complete, preferably 2 hours after addition of the acid into the suspension is complete. The suspension is filtered, and the solid is dried to provide the salt of the compound of formula (I). The yield of the salt of the compound of formula (I) is at least about 90%, and the salt of the compound of formula (I) is obtained on a scale of at least 22 grams without purification.
- All processes of preparation, as described above, are supplemented by synthetic methods known in the art of organic chemistry, or modifications and derivatisations that are familiar to those of ordinary skill in the art. The starting materials used herein are commercially available or may be prepared by routine methods known in the art (such as those methods disclosed in standard reference books such as the COMPENDIUM OF ORGANIC SYNTHETIC METHODS, Vol. I-VI (published by Wiley-Interscience)).
- During any of the above and/or following synthetic sequences it may be necessary and/or desirable to protect sensitive or reactive groups on any of the molecules concerned. This can be achieved by means of conventional protecting groups, such as those described in T. W. Greene, Protective Groups in Organic Chemistry, John Wiley & Sons, 1981; T. W. Greene and P. G. M. Wuts, Protective Groups in Organic Chemistry, John Wiley & Sons, 1991, and T. W. Greene and P. G. M. Wuts, Protective Groups in Organic Chemistry, John Wiley & Sons, 1999, which are hereby incorporated by reference.
- The features and advantages of the invention are more fully shown by the following non-limiting examples. These examples illustrate the process of preparation of various compounds of the present invention. Additional compounds within the scope of this invention can be prepared using the methods illustrated in these Examples, either alone or in combination with techniques generally known in the art. As is well known to a person skilled in the art, reactions are performed in an inert atmosphere (including but not limited to nitrogen or argon) where necessary to protect reaction components from air or moisture. Temperatures are given in degrees Celsius (° C.). Solution percentages and ratios express a volume to volume relationship, unless stated otherwise. Flash chromatography is carried out on silica gel (SiO2) according to the procedure of W. C. Still et al., J. Org. Chem., (1978), 43, 2923.
- Reactions were monitored by thin layer chromatography (TLC) and/or HPLC. For the TLC, it was conducted on silica gel 60 F254 (0.2 mm) precoated aluminum foil and visualized using UV light. Analytical HPLC is carried out under standard conditions using a Agilent™ Plus C18, 4.6×150 mm, Part Number: 959994-902, 1.8 μM, elution with a mobile phases of 0.2% H3PO4 and 60 mM NH4PF6 in HPLC grade water (A) and HPLC grade acetonitrile (B). The flow rate and run time are adjusted to the samples being analyzed. UV detection is at 224 and/or 254 nm. 1HNMR (400 MHz or 300 MHz) and 13C NMR (100.6 MHz) spectra were recorded on Bruker or Varian instruments at ambient temperature with TMS or the residual solvent peak as the internal standard. The line positions or multiples are given in ppm (δ) and the coupling constants (J) are given as absolute values in Hertz (Hz). The multiplicities in 1H NMR spectra are abbreviated as follows: s (singlet), d (doublet), t (triplet), q (quartet), quint (quintet), m (multiplet), mc (centered multiplet), br or broad (broadened), AA′BB′. The signal multiplicities in 13C NMR spectra were determined using the DEPT135 pulse sequence and are abbreviated as follows: +(CH or CH3), —(CH2), Cquart (C).
-
- To a 500 mL glass reactor equipped with mechanical stirrer, addition funnel, thermocouple, reflux condenser and nitrogen inlet is charged potassium trimethylsilanolate (TMSOK, 61.2 g, 0.48 mol, 3.2 eq) and 2-methyl tetrahydrofuran (240 mL) to form a suspension. The suspension is stirred at 20-25° C. 2,3-difluoro-4-methyl-6-nitrobenzoic acid (32.5 g, 0.15 mol, 1 eq) is dissolved in 2-MeTHF (75 mL). To the TMSOK suspension, the solution of 2,3-difluoro-4-methyl-6-nitrobenzoic acid is added. The addition is exothermic and the temperature of the reaction mixture rises to 40-50° C. during addition. After charging is complete, the jacket temperature is set at 65-70° C. The suspension is stirred for 2-3 hour, until HPLC sample shows complete conversion. The mixture is cooled down to room temp. The reaction is quenched with water (100 mL), and acidified to pH 1 with HCl aqueous solution (6M, 90 mL). The layers are separated. The upper organic layer is washed with water (150 mL), and distilled under vacuum to minimum volume. The dark brown residue is stirred in 200 mL of mixed solvent of toluene/methylcyclohexane (v/v, 2:1) to give a suspension. The slurry is filtered. The solid is dried under vacuum to provide the desired product, 2-fluoro-3-hydroxy-4-methyl-6-nitrobenzoic acid (29 g, 90% yield).
- Other compounds as contemplated in the present invention can be synthesized via similar preparation procedures as outlined above.
-
- 5-hydroxy-4-methoxy-2-nitrobenzoic acid (31.9 g, 0.15 mol, 1.0 eq) and 2-methyltetrahydrofuran (200 mL) are charged into a glass reactor under nitrogen. The solution is stirred and jacket temp is set to 20° C. Oxalyl chloride (24 g, 0.19 mol, 1.25 eq) is added at a rate that the internal temperature is below 25° C. The reaction mixture is stirred for 1-2 hour at 20° C., and cooled to 15° C. Then, anhydrous MeOH (60 ml, 1.5 mol, 10 eq) is added over 15 min, and the reaction temperature is maintained below 25° C. during addition. The reaction mixture is stirred for 2-4 hour at 20° C. until HPLC sample shows complete conversion. Na2CO3 aqueous solution (1 M, 100 ml) is added to the reaction mixture. Layers are separated. The upper organic layer is distilled under vacuum to minimum volume. The dark brown residue is stirred in 100 mL mixed solvent of toluene/hexane (v/v, 2:1) to give a suspension. The slurry is filtered. The solid is dried under vacuum to provide the desired product, methyl 5-hydroxy-4-methoxy-2-nitrobenzoate (31.3 g, 92% yield).
- Other compounds as contemplated in the present invention can be synthesized via similar preparation procedures as outlined above.
-
- Palladium on carbon (5 wt.%, wet, contains ˜50% water, 2.4 g, 0.56 mmol, 0.005 eq) is charged into a 300 mL Parr bomb. Then, methyl 5-hydroxy-3-methyl-2-nitrobenzoate (23.2 g, 0.11 mol, 1 eq) and MeOH (80 mL) are charged. The bomb is sealed, and pressurized/vented three times with hydrogen, and pressured with 100 psi hydrogen. The reaction mixture is stirred, until the hydrogen pressure is not dropping. The bomb is opened, and an HPLC sample shows that the reaction is complete. The mixture is diluted with 80 ml of THF and filtered through a Celite pad. The solution is concentrated under vacuum and solvent is switched to EtOAc. To the suspension in EtOAc (150 mL) at 15° C., HCl in dioxane (4M, 36 mL, 0.14 mol, 1.3 eq) is charged at a rate that the internal temperature is below 30° C. The suspension is stirred at 20° C. for 2 hour. The slurry is filtered. The solid is dried under vacuum to provide the desired product, 2-amino-5-hydroxy-3-methylbenzoate hydrochloride (21.5 g, 90% yield).
- Other compounds as contemplated in the present invention can be synthesized via similar preparation procedures as outlined above.
-
- To a 1 L reactor equipped with mechanical stirrer, addition funnel, thermocouple, reflux condenser and nitrogen inlet was charged 4,5-Difluoro-2-nitrobenzoic acid (82 g, 0.4 mol, 1 eq) and water (120 mL) to form a suspension. The suspension was heated to about 50° C. Solution of KOH in water (45 wt. %, 161 g, 1.3 mol, 3.25 eq) was slowly added over about 20 min so that the temperature of the exothermic reaction mixture was kept at 80-90° C. After addition, the mixture was stirred at about 80° C. for about half hour, until HPLC sample showed complete conversion. The mixture was cooled down to room temperature, acidified to pH 1 with concentrated HCl solution (105 ml, 1.26 mol, 3.2 eq), and extracted with 2-methyltetrahydrofuran (630 mL). The layers were separated. The upper organic layer was washed with water (150 mL), and distilled under vacuum to minimum volume.
- The dark brown residue was stirred in 200 mL of mixed solvent of toluene/methylcyclohexane (v/v, 2:1) to give a suspension. The slurry was filtered. The desired product, 4-fluoro-5-hydroxy-2-nitrobenzoic acid, was obtained as an off-white solid after drying under vacuum (68 g, 85% yield). 1H NMR (DMSO-d6, 400 MHz) δ 13.64 (br, 1H), 11.84 (br, 1H), 8.03 (d, J=8.0 Hz, 1H), 7.25 (d, J=12.1 Hz, 1H). 13C NMR (DMSO-d6, 100 MHz) δ 166.0, 151.6, 150.3, 150.2, 149.1, 138.4, 138.3, 127.0, 117.3, 113.7, 113.5.
-
- Starting material 4-fluoro-5-hydroxy-2-nitrobenzoic acid, 68 g, 0.34 mol, 1.0 eq) and methanol (140 mL) were charging into a reactor under nitrogen. The solution was cooled to 10-15° C. Sulfuric acid (120 g, 1.2 mol, 3.5 eq) was added at a rate that the internal temperature was below 30° C. The reaction mixture was refluxed at 65-75° C. for 12-15 hour until HPLC sample showed the conversion was higher than 96%. The mixture was concentrated to minimum volume and the residue was charged into cold water (400 mL) slowly so that the batch was kept below 25° C. The resulting suspension was stirred at 10-15° C. for about 2 hours. The slurry was filtered. The desired product, methyl 4-fluoro-5-hydroxy-2-nitrobenzoate, was obtained as a light brown solid after drying under vacuum (62 g, 85% yield). 1H NMR (CDCl3, 400 MHz) δ 7.84 (d, J=9.7 Hz, 1H), 7.25 (d, J=8.4 Hz, 1H), 6.66 (s, 1H), 3.93 (s, 3H). 13C NMR (DMSO-d6, 100 MHz) δ 165.3, 157.6, 151.9, 151.0, 150.8, 149.4, 138.0, 137.9, 125.9, 117.4, 114.1, 113.8, 53.3.
-
- Palladium on carbon (2.5 wt. %, wet, 8.5 g, 0.005 eq) was charged into a 1 L Parr bomb. Then, methyl 4-fluoro-5-hydroxy-2-nitrobenzoate, 62 g, 0.29 mol, 1 eq) and MeOH (300 mL) were charged. The bomb was sealed, and pressurized/vented three times with hydrogen, and pressured with 100 psi hydrogen. The reaction mixture was stirred, until the hydrogen pressure was not dropping. The bomb was opened, and an HPLC sample showed that the reaction was complete. The mixture was diluted with 400 ml of THF and filtered through a Celite pad. The solution was concentrated under vacuum and solvent was switched to MeOH. To the thick suspension in MeOH, water (150 mL) was added in about 30 min. The slurry was filtered. The desired product, methyl 2-amino-4-fluoro-5-hydroxybenzoate, was obtained as off-white solid after drying under vacuum (45.5 g, 85% yield). 1H NMR (DMSO-d6, 400 MHz) δ 9.05 (s, 1H), 7.28 (d, J=10.0 Hz, 1H), 6.54 (d, J=13.4 Hz, 1H), 6.30 (s, 2H), 3.74 (s, 3H). 13C NMR (DMSO-d6, 100 MHz) δ 167.0, 157.0, 154.5, 146.2, 146.1, 134.5, 134.4, 118.2, 104.7, 103.3, 51.4.
Claims (35)
1. A process of preparing a compound of formula (I) or a salt thereof,
wherein
R1 is (C1-6)alkyl, or (C3-12)cycloalkyl;
R2, R3, and R4 are each independently selected from H, F, Cl, CF3, CN, —OH, —NH2, (C1-6)alkyl, (C3-12)cycloalkyl, —O—(C1-6)alkyl, —NH(C1-6)alkyl, —NH(C3-12)cycloalkyl, —N((C1-6)alkyl(C3-12)cycloalkyl) and —N((C1-6)alkyl)2; wherein each of R1 to R4 is optionally substituted by one or more substituents selected from H, F, Cl, CF3, OXO, CF3, CN, (C1-6)alkyl, (C3-12)cycloalkyl, —OH, —SH, —O(C1-6)alkyl, —S(C1-6)alkyl, —NH2, —NH(C1-6)alkyl, aryl and heteroaryl;
comprising:
Step A: converting a compound of formula (II) to a compound of formula (III) according to reaction scheme 1:
wherein the compound of Formula (I) is reacted with a suitable amount of potassium trimethylsilanolate (TMSOK) in the presence of a suitable solvent at a suitable reaction temperature for a suitable reaction time to provide the compound of formula (III), wherein said compound of formula (III) is obtained via a suitable isolation procedure;
Step B: converting the compound of formula (III) to a compound of formula (IV) according to reaction scheme 2:
wherein the compound of formula (III) is reacted with a suitable amount of oxalyl chloride in the presence of a suitable solvent and at a suitable reaction temperature for a suitable reaction time to form an acid chloride intermediate; and then said acid chloride intermediate is reacted with a suitable amount of alcohol at a suitable reaction temperature for a suitable reaction time to provide the compound of formula (IV), wherein said compound of formula (IV) is obtained via a suitable isolation procedure; and
Step C: converting the compound for formula (IV) to a compound of formula (I) according to reaction scheme 3:
2. The process of claim 1 , wherein the suitable solvent in scheme 1 of Step A is 2-methyltetrahydrofuran (MeTHF).
3. The process of claim 1 , wherein the isolation procedure of Step A comprise cooling the reaction mixture to room temperature after the reaction is complete, quenching the reaction by adding water, adjusting the pH of the reaction mixture to be acidic, separating the organic layer from the aqueous layer of the reaction mixture, washing the organic layer with water, reducing the volume of organic layer to form a residue of the crude product, stirring the residue of the crude product in a solvent to form a slurry suspension, filtering the slurry suspension, and drying the solid to provide the compound of formula (III).
4. The process of claim 1 , wherein the suitable solvent to form the acid chloride intermediate in scheme 2 of Step B is 2-methyltetrahydrofuran (MeTHF).
5. The process of claim 1 , wherein the suitable amount of oxalyl chloride in Step B is 1-1.5 equivalents compared to the amount of the compound of formula (III).
6. The process of claim 1 , wherein the alcohol of Step B is anhydrous methanol, or ethanol.
7. The process of claim 1 , wherein yield of the Step B is at least about 92%.
8. The process of claim 1 , wherein the isolation procedure of Step B comprises adjusting the pH of the reaction mixture to be neutral by adding basic reagents into the reaction mixture after the reaction is complete, separating the organic layer from the aqueous layer of the reaction mixture, reducing the volume of organic layer to form a residue of the crude product, stirring the residue of the crude product in a solvent to form a slurry suspension, filtering the slurry suspension, and drying the solid to provide the compound of formula (IV).
9. The process of claim 1 , wherein the catalyst of Step C comprises palladium on carbon.
10. The process of claim 1 , wherein the solvent of Step C comprises methanol, ethanol, water, acetic acid or mixture of two or more of the solvents.
11. The process of claim 1 , wherein the isolation procedure of Step C comprises diluting the reaction mixture with tetrahydrofuran (THF) after the reaction is complete, filtering the resulting mixture through a Celite pad, concentrating the filtrate and drying the filtrate to provide the compound of formula (I).
12. The process of claim 1 , wherein the compound of formula (I) is further converted to a salt thereof, comprises adding a solvent to the compound of formula (I) obtained from Step C to form a suspension, adding a suitable acid into the suspension at a rate where the temperature of the suspension is maintained below a suitable temperature, and stirring the suspension at a suitable temperature for a suitable reaction time to provided the salt of the compound of formula (I), wherein said salt of the compound of formula (I) is obtained via a suitable isolation procedure.
13. The process of claim 1 , wherein said acid is hydrochloric acid.
17. A process of preparing a compound of formula (I) or a salt thereof,
wherein
R1 is (C1-6)alkyl, or (C3-12)cycloalkyl;
R2, R3, and R4 are each independently selected from H, F, Cl, CF3, CN, —OH, —NH2, (C1-6)alkyl, (C3-12)cycloalkyl, —O—(C1-6)alkyl, —NH(C1-6)alkyl, —NH(C3-12)cycloalkyl, —N((C1-6)alkyl(C3-12)cycloalkyl) and —N((C1-6)alkyl)2; wherein each of R1 to R4 is optionally substituted by one or more substituents selected from H, F, Cl, CF3, OXO, CF3, CN, (C1-6)alkyl, (C3-12)cycloalkyl, —OH, —SH, —O(C1-6)alkyl, —S(C1-6)alkyl, —NH2, —NH(C1-6)alkyl, aryl and heteroaryl;
comprising:
Step A: converting a compound of formula (II) to a compound of formula (III) according to reaction scheme 1:
wherein the compound of Formula (II) is reacted with a suitable amount of KOH, or NaOH in the presence of a suitable solvent at a suitable reaction temperature for a suitable reaction time to provide the compound of formula (III), wherein said compound of formula (III) is obtained via a suitable isolation procedure;
Step B: converting the compound of formula (III) to a compound of formula (IV) according to reaction scheme 2:
wherein the compound of formula (III) is reacted with a suitable amount of H2SO4 in the presence of a suitable solvent and at a suitable reaction temperature for a suitable reaction time to form a compound of formula (IV), wherein said compound of formula (IV) is obtained via a suitable isolation procedure; and
Step C: converting the compound for formula (IV) to a compound of formula (I) according to reaction scheme 3:
18. The process of claim 17 wherein the suitable solvent of Step A comprises water and the reaction temperature is about 85 to 95°.
19. The process of claim 17 wherein the the reaction time of Step A is 10 to 30 minutes.
20. The process of claim 17 where the suitable amount of KOH or NaOH is about 3-4 eq.
21. The process of claim 17 wherein the yield is about 85%.
22. The process of claim 17 wherein the isolation procedure of Step A comprises cooling down to room temperature, and extracting with 2-methyltetrahydrofuran and separating the layers; washing the organic layer with water and distilling under vacuum to minimum volume; stirring the residue with a solvent of toluene/methylcyclohexanet to give a suspension; and filtering the product to provide a compound of formula III.
23. The process of claim 17 wherein the compound of formula III is reacted with H2SO4 to provide a compound of formula IV.
24. The process of claim 17 wherein the reaction temperature is 65-75°.
25. The process of claim 17 wherein the yield is about 85%.
26. The process of claim 17 , wherein the suitable solvent in scheme 2 of Step B is MeOH or EtOH.
27. The process of claim 17 , wherein the suitable amount of sulfuric acid is 1-4 equivalents to the amount of the compound of formula (III).
28. The process of claim 17 wherein the catalyst of step C comprises palladium on carbon.
29. The process of claim 17 wherein the suitable amount of the catalyst of Step C is from 0.001 to 0.05 equivalent compared to the amount of the compound of formula (IV).
30. The process of claim 17 , wherein the solvent of Step C comprises methanol, ethanol, water, acetic acid or mixture of two or more of the solvents.
31. The process of claim 17 , wherein the solvent of Step C comprises methanol.
32. The process of claim 17 , wherein the isolation procedure of Step C comprises diluting the reaction mixture with tetrahydrofuran (THF) after the reaction is complete, filtering the resulting mixture through a Celite pad, concentrating the filtrate and drying the filtrate to provide the compound of formula (I).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/948,867 US20130310597A1 (en) | 2009-10-05 | 2013-07-23 | Process for preparation of substituted p-aminophenol |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24871709P | 2009-10-05 | 2009-10-05 | |
US12/896,602 US8519176B1 (en) | 2009-10-05 | 2010-10-01 | Process for preparation of substituted P-aminophenol |
US13/948,867 US20130310597A1 (en) | 2009-10-05 | 2013-07-23 | Process for preparation of substituted p-aminophenol |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/896,602 Continuation US8519176B1 (en) | 2009-10-05 | 2010-10-01 | Process for preparation of substituted P-aminophenol |
Publications (1)
Publication Number | Publication Date |
---|---|
US20130310597A1 true US20130310597A1 (en) | 2013-11-21 |
Family
ID=48999717
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/896,602 Active 2031-08-24 US8519176B1 (en) | 2009-10-05 | 2010-10-01 | Process for preparation of substituted P-aminophenol |
US13/948,867 Abandoned US20130310597A1 (en) | 2009-10-05 | 2013-07-23 | Process for preparation of substituted p-aminophenol |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/896,602 Active 2031-08-24 US8519176B1 (en) | 2009-10-05 | 2010-10-01 | Process for preparation of substituted P-aminophenol |
Country Status (1)
Country | Link |
---|---|
US (2) | US8519176B1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104458966A (en) * | 2014-12-23 | 2015-03-25 | 南京市产品质量监督检验院 | Detection method for forbidden azo dyes of textiles |
CN106153780A (en) * | 2016-07-29 | 2016-11-23 | 杭州吉华江东化工有限公司 | A kind of detect the method for organochlorine residue in azo dye product |
CN113912499A (en) * | 2021-11-29 | 2022-01-11 | 八叶草健康产业研究院(厦门)有限公司 | 4-fluoro-5-hydroxy-2-nitrobenzoic acid methyl ester |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5514676A (en) * | 1984-03-19 | 1996-05-07 | The Rockefeller University | Amino-benzoic acids and derivatives, and methods of use |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007113337A1 (en) * | 2006-04-06 | 2007-10-11 | Tibotec Pharmaceuticals Ltd. | A homogeneous time resolved fluorescence based test system |
US8242140B2 (en) * | 2007-08-03 | 2012-08-14 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
CN101998959B (en) * | 2008-02-06 | 2013-08-28 | 生物马林药物股份有限公司 | Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP) |
EP2350039A4 (en) * | 2008-10-03 | 2012-10-10 | Boehringer Ingelheim Int | Viral polymerase inhibitors |
CN102753533B (en) * | 2009-12-11 | 2014-07-30 | 奥蒂福尼疗法有限公司 | Imidazolidinedione derivatives |
-
2010
- 2010-10-01 US US12/896,602 patent/US8519176B1/en active Active
-
2013
- 2013-07-23 US US13/948,867 patent/US20130310597A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5514676A (en) * | 1984-03-19 | 1996-05-07 | The Rockefeller University | Amino-benzoic acids and derivatives, and methods of use |
Also Published As
Publication number | Publication date |
---|---|
US8519176B1 (en) | 2013-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6061158B2 (en) | Synthesis intermediate of 6- (7-((1-aminocyclopropyl) methoxy) -6-methoxyquinolin-4-yloxy) -N-methyl-1-naphthamide, or a pharmaceutically acceptable salt thereof, and its use | |
US10494372B2 (en) | Synthesis of copanlisib and its dihydrochloride salt | |
JP7100125B2 (en) | Process for improved preparation of ribociclib and its salts | |
US7799916B2 (en) | Process for the preparation of 5-(4-[4-(5-cyano-3-indolyl)butyl]-1-piperazinyl)benzofuran-2-carboxamide | |
CN102639486B (en) | Process for manufacture of N-acylbphenyl alanine | |
US9834561B2 (en) | Process for preparing ibrutinib and its intermediates | |
JP2017536352A (en) | Synthesis of copanricib and its dihydrochloride | |
US8519176B1 (en) | Process for preparation of substituted P-aminophenol | |
KR20080036058A (en) | Method for preparing 4β-amino-4'-dimethyl-4-decoxypodophyllotoxin | |
KR102453655B1 (en) | Improved process for preparing acotiamide | |
US8410091B1 (en) | Process for preparation of substituted 2-amino-5-(5-(heterocyclemethyl)pyridin-2-yloxy)benzoic acid | |
US7473778B2 (en) | 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-one | |
JP2010520158A (en) | Novel process for the preparation of 3-methyl-4-phenylisoxazolo [3,4-d] pyridazin-7 (6H) -one | |
CN115850237A (en) | Synthetic method of indole derivative | |
KR102389716B1 (en) | Method For Preparing Indole Or Indazole Compound | |
Ahmed et al. | A straightforward and mild method of tethering monosaccharides to thieno [2, 3-d] pyrimidinones via the copper (I)-catalyzed azide-alkyne ‘Click Chemistry’ | |
HK1231871A1 (en) | A process for the preparation of compound and synthetic intermediates thereof | |
WO2022034427A1 (en) | An improved process for the preparation of 4-oxoisotretinoin | |
Li et al. | Soluble poly (ethylene glycol) supported efficient synthesis of 2, 5‐disubstituted 1, 3, 4‐oxadiazoles and 1, 3, 4‐thiadiazoles | |
US20250092026A1 (en) | Method for preparing benzofuran derivative | |
JP4416111B2 (en) | Method for producing 2,3-diaminopyridine derivative | |
CN112979643A (en) | 3-(2-Chloroethyl)-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one | |
HK1167136B (en) | A process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and synthetic intermediates thereof | |
CN110551114A (en) | Preparation method of raltitrexed | |
HK1196132B (en) | Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |